Effect of compounds with antibacterial activities in human milk on respiratory syncytial virus and cytomegalovirus in vitro

References

1. Lasgreid A., Kolstø Otnasss A.-B., Ørstavik I., Carlsen K. H. Neutralizing activity in human milk fractions against respiratory syncytial virus. Acta Paediatr Scand 1986; 75:696–701
   [Google Scholar]
2. Toms G. L., Gardner P. S., Pullan C. R., Scott M., Taylor C. Secretion of respiratory syncytial virus inhibitors and antibody in human milk throughout lactation. J Med Virol 1980; 5:351–360
   [Google Scholar]
3. Grover M., Giouzeppos O., Schnagl R. D., May J. T. Effect of human milk prostaglandins and lactoferrin on respiratory syncytial virus and rotavirus. Acta Paediatr 1997; 86:315–316
   [Google Scholar]
4. Harmsen M. C., Swart P. J., de Bethune M.-P. Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. J Infect Dis 1995; 172:380–388
   [Google Scholar]
5. Hasegawa K., Motsuchi W., Tanaka S., Dosako S. Inhibition with lactoferrin of in vitro infection with human herpes virus. Jpn J Med Sci Biol 1994; 47:73–85
   [Google Scholar]
6. May J. T. Antimicrobial factors and microbial contaminants in human milk: recent studies. J Paediatr Child Health 1994; 30:470–475
   [Google Scholar]
7. Laegreid A., Otnaess A.-B.K., Fuglesang J. Human and bovine milk: comparison of ganglioside composition and enterotoxin-inhibitory activity. Pediatr Res 1986; 20:416–421
   [Google Scholar]
8. Rueda R., Maldonado J., Gil A. Comparison of content and distribution of human milk gangliosides from Spanish and Panamanian mothers. Ann Nutr Metab 1996; 40:194–201
   [Google Scholar]
9. Idota T., Kawakami H., Murakami Y., Sugawara M. Inhibition of cholera toxin by human milk fractions and sialyllactose. Biosci Biotechnol Biochem 1995; 59:417–419
   [Google Scholar]
10. Newburg D. S., Linhardt R. J., Ampofo S. A., Yolken R. H. Human milk glycosaminoglycans inhibit HIV glycoprotein gp120 binding to its host cell CD4 receptor. J Nutr 1995; 125:419–424
    [Google Scholar]
11. Idota T., Kawakami H. Inhibitory effects of milk gangliosides on the adhesion of Escherichia coli to human intestinal carcinoma cells. Biosci Biotech Biochem 1995; 59:69–72
    [Google Scholar]
12. Rolsma M. D., Gelberg H. B., Kuhlenschmidt M. S. Assay for evaluation of rotavirus-cell interactions: identification of an enterocyte ganglioside fraction that mediates group A porcine rotavirus recognition. J Virol 1994; 68:258–268
    [Google Scholar]
13. Superti F., Donelli G. Gangliosides as binding sites in SA-11 rotavirus infection of LLC-MK2 cells. J Gen Virol 1991; 72:2467–2474
    [Google Scholar]
14. Willoughby R. E., Yolken R. H., Schnaar R. L. Rotaviruses specifically bind to the neutral glycosphingolipid asialo-GM1. J Virol 1990; 64:4830–4835
    [Google Scholar]
15. Kunz C., Rudloff S. Biological functions of oligosaccharides in human milk. Acta Paediatr 1993; 82:903–912
    [Google Scholar]
16. Welsh J. K., Skurrie I. J., May J. T. Use of Semliki Forest virus to identify lipid-mediated antiviral activity and anti-alphavirus immunoglobulin A in human milk. Infect Immun 1978; 19:395–401
    [Google Scholar]
17. Welsh J. M., Arsenakis M., May J. T. Effect on Semliki Forest virus and Coxsackie B4 of lipids common to human milk. J Food Safety 1981; 3:99–107
    [Google Scholar]
18. Isaacs C. E., Litov R. E., Thormar H. Antimicrobial activity of lipids added to human milk, infant formula, and bovine milk. J Nutr Biochem 1995; 6:362–366
    [Google Scholar]
19. May J. T. Microbial contaminants and antimicrobial properties of human milk. Microbiol Sci 1988; 5:42–46
    [Google Scholar]